Intravenous Antiarrhythmic Drugs: Newer Aspects of Therapy
- tocainide. // Davis's Drug Guide for Nurses, 10th edition;2007, p1157
This article presents a nurse's guide to the antiarrhytmic agent tocainide. Tocainide is indicated for the treatment of life-threatening ventricular arrhythmias, including multifocal and unifocal premature ventricular contractions and ventricular tachycardia. Tocainide works by suppressing...
- Narrow-complex tachycardia. Giudici, Michael C.; Gumpert, Tamra J. // American Family Physician;3/1/1994, Vol. 49 Issue 4, p823
Reviews the pathophysiology, diagnosis and treatment of narrow-complex tachycardia. Types; Mechanism of tachyarrythmias; Factors influencing automaticity in tachyarrythmias; Antiarrthymic drug classification.
- Pharmacologic management of cardiac arrhythmias. Gi-Byoung Nam // Journal of the Korean Medical Association / Taehan Uisa Hyophoe ;May2013, Vol. 56 Issue 5, p425
Management of cardiac arrhythmias involves antiarrhythmic drugs (AADs), catheter ablation, pacemakers, and implantable defibrillators. The effects of AADs are mediated by blocking various cardiac ion channels, mostly the cardiac sodium, calcium, or potassium channels. A simple classification of...
- Lidocaine may block an ATP-dependent K+ channel. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;12/20/97, Vol. 10 Issue 12, p20
Reports that class IB antiarrhythmic drugs are less powerful sodium ion (Na+) channel blockers than class IA drugs. Reason why class IB agents are less powerful.
- Ablation of incessant orthodromic reciprocating tachycardia in a child with congenitally corrected transposition of great arteries and ebsteinoid malformation of left atrioventricular valve. Chandrakant Chavan; Hygriv Rao; Rajesh Badani; P. Raju; C. Narasimhan // Journal of Interventional Cardiac Electrophysiology;Nov2008, Vol. 23 Issue 2, p149
AbstractÂ Â We report about a patient with congenitally corrected transposition of the great arteries and ebsteinoid malformation of left atrioventricular (AV) valve who presented with incessant orthodromic atrioventricular reciprocating tachycardia due to a left posteroseptal accessory...
- Adverse reactions during treatment with amiodarone hydrochloride. McGovern, Brian; Garan, Hasan; Kelly, Elizabeth; Ruskin, Jeremy N. // British Medical Journal (Clinical Research Edition);7/16/1983, Vol. 287 Issue 6386, p175
Investigates on the adverse reactions during treatment with amiodarone hydrochloride. Administration of amiodarone on 80 patients with recurrent cardiac tachyarrhythmias; Treatment of 49 patients for ventricular tachycardia or fibrillation; Side-effects of drugs; Use of antiarrhythmic drugs.
- Rate-Dependence of Antiarrhythmic Drug Action. Singh, Bramah N.; Wadhani, Nitin; Sarma, Jonnalagedda S. M. // Journal of Cardiovascular Pharmacology & Therapeutics;Oct2002, Vol. 7 Issue 4, p203
This article focuses on the rate-dependence of antiarrhythmic drug action. Much change has occurred in recent years in the role of antiarrhythmic drugs in the control of cardiac arrhythmias. A precise understanding of the mechanisms of cardiac arrhythmias has led to electrode catheter ablation...
- Searching for the Ideal Class III Antiarrhythmic Agent: How Pure Should They Be? Singh, Bramah N. // Journal of Cardiovascular Pharmacology & Therapeutics;Dec1997, Vol. 2 Issue 4, p239
The article discusses the search for the ideal Class III antiarrhythmic agent. While methods to control cardiac arrhythmias reportedly evolve rapidly with radiofrequency catheter ablation and implantable devices as the biggest advances, progress has been moderate with finding newer drugs. The...
- Update on Atrial Fibrillation: Restoration of Sinus Rhythm or Ventricular Rate Control? Yi-Gang Li; Hohnloser, Stefan H. // Journal of Cardiovascular Pharmacology & Therapeutics;Jun1998, Vol. 3 Issue 2, p185
The article discusses therapeutic alternatives for patients with persistent atrial fibrillation. It summarizes the present knowledge on this clinical problem with particular emphasis on issues such as efficacy of antiarrhythmic drugs to prevent recurrent atrial fibrillation, proarrhythmic...